City

Condition

ALL, Infants (1)

Acute Lymphoblastic Leukemia, Pediatric (1)

Overall Status

Not yet recruiting (1)

Phase

phase 3 (1)

Sponsor

Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1)

Collaborator

Intervention

the risk-adapted choice of therapy and the use of a combination of chemotherapy with immunotherapy and hematopoietic stem cell transplantation for patients with risk factors. (1)

Study Documents

Intervention Type

combination product (1)

Funder Type

Other (1)

Study Type

Interventional (1)

all, infants

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Lymphoblastic Leukemia, Pediatric, ALL, Infants Trial (the risk-adapted choice of therapy and the use of a combination of

Not yet recruiting

Acute Lymphoblastic Leukemia, Pediatric
ALL, Infants

the risk-adapted choice of therapy and the use of a combination of chemotherapy with immunotherapy and hematopoietic stem cell transplantation for patients with risk factors.

(no location specified)

Aug 26, 2021